MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

27.51 +0.07 (+0.26%)
Official Closing Price Updated: 7:00 PM EDT, Sep 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
40 41 Next >
News headline image
I'm Calling It: Hims & Hers Health Will Soar 56% by the End of 2026 ↗
Hims & Hers Health is still growing rapidly, but whether that growth can translate into better economics could determine how much further the stock can climb. 
Via The Motley Fool
News headline image
MarketBeat Week in Review – 08/24 - 08/28 ↗
MarketBeat analysts recap a mixed earnings week, covering AI infrastructure demand, retail's K-shaped consumer trends, Meta's $18 billion settlement, and stock picks across tech, biotech, and retail... 
Via MarketBeat
Topics Artificial Intelligence Bonds Economy
News headline image
After Doubling in Six Months, Is it Too Late to Buy Hims & Hers Stock? ↗
The healthcare industry is ripe for disruption. 
Via The Motley Fool
News headline image
Unpacking Q2 Earnings: Hims & Hers Health (NYSE:HIMS) In The Context Of Other Healthcare Technology Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Hims & Hers Health (NYSE:HIMS... 
Via StockStory
News headline image
Stocks making big moves yesterday: Funko, Hims & Hers Health, Azenta, Strategy, and RUM Group
Check out the companies making headlines yesterday: Funko (NASDAQ:FNKO): Pop culture collectibles manufacturer Funko (NASDAQ:FNKO) rose by 4.9% on Monday aft... 
Via StockStory
Topics Artificial Intelligence Credit Cards
News headline image
Why Hims & Hers Health (HIMS) Stock Is Nosediving
What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 9.2% in the afternoon session after Bloomberg reported that Visa enrolled the... 
Via StockStory
Topics Credit Cards Lawsuit
News headline image
Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters ↗
Visa placed Hims & Hers Health into its Acquirer Monitoring Program after a billing dispute spike, adding penalty costs amid an FTC lawsuit and margin contraction. 
Via MarketBeat
Topics Credit Cards Lawsuit
News headline image
2 Unpopular Stocks That Deserve a Second Chance and 1 We Ignore
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea... 
Via StockStory
News headline image
Hims & Hers' Chief Accounting Officer Is Leaving. Here's What Her Latest Insider Filing Shows ↗
This filing notes that shares were withheld automatically to cover tax obligations from quarterly RSU vesting. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
An Insider at Hims & Hers Just Filed. Here's What It Says About Buying the Dip ↗
Soleil Boughton retains roughly 339,000 shares and additional derivative securities. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What Long-Term Investors Should Know About This Hims Insider Filing ↗
This tax-related withholding was tied to quarterly RSU vesting, not discretionary selling. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
A Hims & Hers Insider Disposed of Stock as the Company Pushes Into Testosterone and Peptides. Here's What to Know ↗
Tax withholding drove the disposal of 10,201 shares at $28.15 each, reducing this insider's direct holdings by 5%, though they're still up on a net basis given conversions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Hims & Hers' Policy Chief Just Filed an Insider Transaction. Here's What It Means. ↗
This non-discretionary sale was tied to RSU tax withholding; the insider retains 65,734 direct shares and 428,000 derivative securities, per the filing. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
An Insider at Hims & Hers Disposed of Over $3 Million in Stock. Here's What Long-Term Investors Should Know ↗
The disposition comes as HIMS stock has declined 38% over the past 12 months. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The CTO of Hims & Hers Just Gave Up Nearly $2.7 Million in Stock. Here's What It Actually Means ↗
This non-discretionary tax withholding reduced the CTO of Hims' direct holdings, though he retains roughly 194,000 shares and roughly 2 million derivative securities subject to multi-year vesting. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Hims & Hers' CEO Just Disposed of 78,859 Shares. Here's What Long-Term Investors Should Know. ↗
Stock-based compensation vesting triggered mandatory tax withholding, but Dudum retains about 9.7 million shares worth $272 million. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Hims (HIMS) Q2 2026 Earnings Call Transcript ↗
Subscriber growth accelerated as revenue surged 38% and international expansion took off. 
Via The Motley Fool
Topics Earnings
News headline image
5 Revealing Analyst Questions From Hims & Hers Health’s Q2 Earnings Call
Hims & Hers Health’s second quarter results were driven by strong subscriber growth and a ramp-up in its branded weight loss offerings, yet the market reacte... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
3 Market-Beating Stocks to Research Further
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ... 
Via StockStory
News headline image
Hims & Hers’ Revenue Beat Came With a Profitability Problem ↗
Hims & Hers topped Q2 revenue estimates and raised guidance, but missed EPS forecasts, posted a wider net loss, and faces an FTC lawsuit, leaving Wall Street cautious with a Hold rating. 
Via MarketBeat
Topics Earnings Lawsuit
AI Capex Roars On After Hours as Hormuz Stress Keeps Traders on Edge ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
HIMS Q2 Deep Dive: AI Strategy and International Expansion Shape Telehealth Outlook
Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q2 CY2026, with sales up 38.2% year on year to $753.2 million. On... 
Via StockStory
Topics Artificial Intelligence
Wall Street Titans Line Up $500 Billion Behind Nvidia's AI Buildout ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
Hims & Hers Health Q2 Earnings Call Highlights ↗
Hims & Hers Health (NYSE:HIMS) reported second-quarter 2026 revenue of more than $753 million, up nearly 40% from a year earlier, as the telehealth company added 300,000 net new subscribers and ended... 
Via MarketBeat
Topics Earnings
News headline image
Hims & Hers Health (NYSE:HIMS) Exceeds Q2 CY2026 Expectations But Stock Drops
Telehealth company Hims & Hers Health (NYSE:HIMS) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 38.2% year on year to $753... 
Via StockStory
News headline image
Hims & Hers Health Earnings: What To Look For From HIMS
Telehealth company Hims & Hers Health (NYSE:HIMS) will be announcing earnings results this Monday after market hours. Here’s what to expect. Hims & Hers Heal... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Healthcare Stock Worth Your Attention and 2 We Ignore
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
News headline image
The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic ↗
Hims & Hers Health shares have rallied despite an FTC lawsuit over data sharing and billing practices, as weight-loss drug partnerships and Wall Street's cautious Hold rating shape the stock's outlook... 
Via MarketBeat
Topics Lawsuit
News headline image
Is Hims & Hers Health Stock in Trouble? ↗
In the past 12 months, the stock has nosedived more than 50%. 
Via The Motley Fool
News headline image
Bearish Pressure Is Building Around These 3 Stocks ↗
Hims & Hers Health and QXO face heavy short interest amid dilution and loss concerns, while KLA has slid nearly 40% since June as AI-driven chip spending fears grip semiconductor stocks. 
Via MarketBeat
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
40 41 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story